HYPERION DEFI, INC. Inventory Write-down
HYPERION DEFI, INC. (HYPD) reported Inventory Write-down of $3.09 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-03-30
- HYPERION DEFI, INC. inventory write-down for the quarter ending 2024-12-31 was $2.32M.
- HYPERION DEFI, INC. inventory write-down for the quarter ending 2024-09-30 was $100.00K.
- HYPERION DEFI, INC. inventory write-down for the quarter ending 2024-06-30 was $500.00K.
- HYPERION DEFI, INC. inventory write-down for the quarter ending 2024-03-31 was $198.03K.
- HYPERION DEFI, INC. inventory write-down for fiscal 2024 was $3.09M, a 25153.31% increase from fiscal 2023.
- HYPERION DEFI, INC. inventory write-down for fiscal 2023 was $12.22K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.42M derived: sum of 2 quarters · filed 2026-03-30 | $2.92M derived: sum of 3 quarters · filed 2026-03-30 | $3.09M 10-K · filed 2026-03-30 |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-12 | $600.00K derived: sum of 2 quarters · filed 2024-11-12 | $769.22K 10-Q · filed 2025-11-14 | $798.03K derived: sum of 4 quarters · filed 2025-05-19 |
| 2024-06-30 | $500.00K 10-Q · filed 2024-08-14 | $665.77K 10-Q · filed 2025-08-13 | $698.03K derived: sum of 3 quarters · filed 2025-05-19 | $698.03K derived: sum of 4 quarters · filed 2025-05-19 |
| 2024-03-31 | $198.03K 10-Q · filed 2025-05-19 | $198.03K derived: sum of 2 quarters · filed 2025-05-19 | $198.03K derived: sum of 3 quarters · filed 2025-05-19 | $198.03K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 derived: sum of 3 quarters · filed 2025-04-15 | $12.22K 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $12.22K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |